SpaceX shares fell sharply by 16.4% to $154.6 following a volatile debut after its $1.3 trillion IPO, causing significant losses for investors like Scottish Mortgage Investment Trust, which holds 17.9% of its portfolio in SpaceX. The decline also impacted other FTSE tech funds such as Polar Capital Technology Trust and Baillie Gifford US Growth Trust, which fell 3.1%. This drop is part of a broader sell-off in US tech stocks, with major players like Alphabet, Amazon, and Microsoft also seeing notable declines. The sell-off highlights ongoing volatility in tech markets post-IPO and raises concerns about future tech stock performance.
The European Commission has approved Cenrifki (tolebrutinib) by Sanofi for treating secondary progressive multiple sclerosis (SPMS) without relapses, based on positive phase 3 trial results showing it delays disability progression. This is the first ...
argenx, a global immunology company, is hosting a webinar on June 23, 2026, focused on advancing research and development of FcRn blockers for autoimmune myositis. The event features argenx's management and scientific leaders alongside key external e...
Signify announced a new strategy at its 2026 Capital Markets Day to become a more focused and better-performing company by 2029. The plan includes prioritizing growth in connected lighting and consumer segments while optimizing less profitable areas....
The European Commission has approved Sanofi's Cenrifki (tolebrutinib) as the first medicine targeting disability progression in secondary progressive multiple sclerosis (SPMS) without relapses. Approval is based on positive phase 3 clinical trial res...
Akkodis' 2026 study reveals CTO confidence in scaling AI has fallen from 82% in 2024 to 48% in 2026, despite rapid AI adoption and increased investments. The main challenge is not technology but integrating AI into company systems, processes, and dec...
